Matches in Wikidata for { <http://www.wikidata.org/entity/Q92273918> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q92273918 description "clinical trial" @default.
- Q92273918 description "ensayo clínico" @default.
- Q92273918 description "ensayu clínicu" @default.
- Q92273918 description "klinisch onderzoek" @default.
- Q92273918 description "клінічне випробування" @default.
- Q92273918 description "临床试验" @default.
- Q92273918 name "Comparison of Pharmacokinetics and Safety of Recombinant Anti IgE Humanized Monoclonal Antibody for Injection" @default.
- Q92273918 name "Comparison of Pharmacokinetics and Safety of Recombinant Anti IgE Humanized Monoclonal Antibody for Injection(HS632) and Omalizumab With a Single Injection (Xolair®)" @default.
- Q92273918 type Item @default.
- Q92273918 label "Comparison of Pharmacokinetics and Safety of Recombinant Anti IgE Humanized Monoclonal Antibody for Injection" @default.
- Q92273918 label "Comparison of Pharmacokinetics and Safety of Recombinant Anti IgE Humanized Monoclonal Antibody for Injection(HS632) and Omalizumab With a Single Injection (Xolair®)" @default.
- Q92273918 prefLabel "Comparison of Pharmacokinetics and Safety of Recombinant Anti IgE Humanized Monoclonal Antibody for Injection" @default.
- Q92273918 prefLabel "Comparison of Pharmacokinetics and Safety of Recombinant Anti IgE Humanized Monoclonal Antibody for Injection(HS632) and Omalizumab With a Single Injection (Xolair®)" @default.
- Q92273918 P1132 Q92273918-60B870E7-D518-4223-BA5A-244B6DB2C7ED @default.
- Q92273918 P1476 Q92273918-DE7724E3-8B12-4B99-965A-8C508033CF82 @default.
- Q92273918 P2899 Q92273918-3CFBC93C-BD82-4C94-AD7D-56007A89CE59 @default.
- Q92273918 P3098 Q92273918-1D2E9904-DB7D-48F2-867B-A033FF2D8F14 @default.
- Q92273918 P31 Q92273918-81A573E8-0C4B-46FE-B852-E07F2E7DD27D @default.
- Q92273918 P4135 Q92273918-407EDE61-3FFD-46A6-B8DA-60F3BFE37306 @default.
- Q92273918 P4844 Q92273918-7A95BAB0-F3FD-48CF-B8AE-412ECE2133F5 @default.
- Q92273918 P580 Q92273918-EB203220-5BBD-4319-86AF-880617196B78 @default.
- Q92273918 P582 Q92273918-5B5C902B-25DB-4A72-9C48-58386F9C3278 @default.
- Q92273918 P6099 Q92273918-15E0B9E1-1182-48C6-8E7E-CC0BD2363F24 @default.
- Q92273918 P8005 Q92273918-8DF4F95A-B2E6-4A55-8261-981BF403A61D @default.
- Q92273918 P8363 Q92273918-6AC45FA3-34BC-4462-9C2E-A58364B00195 @default.
- Q92273918 P1132 "+252" @default.
- Q92273918 P1476 "A Multicenter, Randomized, Double-blind, Parallel Controlled Phase I Clinical Trial Comparing the Pharmacokinetic and Safety Similarities of Recombinant Anti IgE Humanized Monoclonal Antibody for Injection (HS632) With Omalizumab (Xolair® ) After a Single Dose Administration in Chinese Healthy Subjects" @default.
- Q92273918 P2899 "+18" @default.
- Q92273918 P3098 "NCT04361812" @default.
- Q92273918 P31 Q30612 @default.
- Q92273918 P4135 "+40" @default.
- Q92273918 P4844 Q415392 @default.
- Q92273918 P580 "2020-06-08T00:00:00Z" @default.
- Q92273918 P582 "2021-12-31T00:00:00Z" @default.
- Q92273918 P6099 Q5452194 @default.
- Q92273918 P8005 Q76649614 @default.
- Q92273918 P8363 Q78089383 @default.